THZ1, a specific covalent inhibitor of CDK7, selectively blocks the transcription of super-enhancer-associated oncogenes, such as MYC, MYCN, YAP1, and RUNX1, thereby inducing cancer cell growth inhibition and apoptosis. The gene discussed is CDK7; the disease is cancer.